Biomarkers of morphine tolerance and dependence are prevented by morphine-induced endocytosis of a mutant μ-opioid receptor

FASEB Journal

Volumn 23, Issue 12, 2009, Pages 4327-4334

  He, Li ^a   Kim, Joseph A ^a   Whistler, Jennifer L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenylyl cyclase; c fos; Glucocorticoid receptor; NMDA receptor; Trafficking

Indexed keywords

ADENYLATE CYCLASE; BIOLOGICAL MARKER; GLUCOCORTICOID RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN C FOS;

ARTICLE; BIOCHEMISTRY; BRAIN REGION; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; WILD TYPE;

ANIMALS; BIOLOGICAL MARKERS; DRUG TOLERANCE; ENDOCYTOSIS; GENE KNOCK-IN TECHNIQUES; MICE; MICE, INBRED C57BL; MORPHINE; MUTATION; PAIN MEASUREMENT; RECEPTORS, OPIOID, MU;

MUS;

EID: 72749093104     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-133223     Document Type: Article

References (50)

1. Matthes, H. W., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dolle, P., Tzavara, E., Hanoune, J., Roques, B. P., and Kieffer, B. L. (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383, 819-823 (Pubitemid 26372664)
2. Sora, I., Takahashi, N., Funada, M., Ujike, H., Revay, R. S., Donovan, D. M., Miner, L. L., and Uhl, G. R. (1997) Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. U. S. A. 94, 1544-1549 (Pubitemid 27087888)
3. Yang, Y., Zheng, X., Wang, Y., Cao, J., Dong, Z., Cai, J., Sui, N., and Xu, L. (2004) Stress enables synaptic depression in CA1 synapses by acute and chronic morphine: possible mechanisms for corticosterone on opiate addiction. J. Neurosci. 24, 2412-2420 (Pubitemid 38327954)
4. Inoue, M., Mishina, M., and Ueda, H. (2003) Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J. Neurosci. 23, 6529-6536 (Pubitemid 36909879)
5. Pasternak, G. W. (2007) When it comes to opiates, just say NO. J. Clin. Invest. 117, 3185-3187
6. Trujillo, K. A., and Akil, H. (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87
7. Lim, G., Wang, S., Zeng, Q., Sung, B., Yang, L., and Mao, J. (2005) Expression of spinal NMDA receptor and PKCγ after chronic morphine is regulated by spinal glucocorticoid receptor. J. Neurosci. 25, 11145-11154 (Pubitemid 43089559)
8. Lim, G., Wang, S., Zeng, Q., Sung, B., and Mao, J. (2005) Spinal glucocorticoid receptors contribute to the development of morphine tolerance in rats. Anesthesiology 102, 832-837 (Pubitemid 40462864)
9. Marinelli, M., Aouizerate, B., Barrot, M., Le Moal, M., and Piazza, P. V. (1998) Dopamine-dependent responses to morphine depend on glucocorticoid receptors. Proc. Natl. Acad. Sci. U. S. A. 95, 7742-7747 (Pubitemid 28293324)
10. Kim, J. A., Bartlett, S., He, L., Nielsen, C. K., Chang, A. M., Kharazia, V., Waldhoer, M., Ou, C. J., Taylor, S., Ferwerda, M., Cado, D., and Whistler, J. L. (2008) Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Curr. Biol. 18, 129-135
11. Duttaroy, A., and Yoburn, B. C. (1995) The effect of intrinsic efficacy on opioid tolerance. Anesthesiology 82, 1226-1236
12. Sternini, C., Spann, M., Anton, B., Keith, D. E., Jr., Bunnett, N. W., von Zastrow, M., Evans, C., and Brecha, N. C. (1996) Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. U. S. A. 93, 9241-9246 (Pubitemid 26282048)
13. He, L., Fong, J., von Zastrow, M., and Whistler, J. L. (2002) Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108, 271-282 (Pubitemid 34161146)
14. He, L., and Whistler, J. L. (2005) An opiate cocktail that reduces morphine tolerance and dependence. Curr. Biol. 15, 1028-1033 (Pubitemid 40772150)
15. Trafton, J. A., Abbadie, C., Marek, K., and Basbaum, A. I. (2000) Postsynaptic signaling via the μ-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation. J. Neurosci. 20, 8578-8584
16. Keith, D. E., Anton, B., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D. V., Monteillet-Agius, G., Stewart, P. L., Evans, C. J., and von Zastrow, M. (1998) μ-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol. Pharmacol. 53, 377-384 (Pubitemid 28162857)
17. Koob, G. F., Maldonado, R., and Stinus, L. (1992) Neural substrates of opiate withdrawal. Trends Neurosci. 15, 186-191
18. Izenwasser, S., Buzas, B., and Cox, B. M. (1993) Differential regulation of adenylyl cyclase activity by μ and δ opioids in rat caudate putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 267, 145-152 (Pubitemid 23325001)
19. Wang, Y. H., Bosy, T. Z., Yasuda, R. P., Grayson, D. R., Vicini, S., Pizzorusso, T., and Wolfe, B. B. (1995) Characterization of NMDA receptor subunit-specific antibodies: distribution of NR2A and NR2B receptor subunits in rat brain and ontogenic profile in the cerebellum. J. Neurochem. 65, 176-183
20. Grecksch, G., Bartzsch, K., Widera, A., Becker, A., Hollt, V., and Koch, T. (2006) Development of tolerance and sensitization to different opioid agonists in rats. Psychopharmacology 186, 177-184 (Pubitemid 43727334)
21. Koch, T., Schulz, S., Pfeiffer, M., Klutzny, M., Schroder, H., Kahl, E., and Hollt, V. (2001) C-terminal splice variants of the mouse μ-opioid receptor differ in morphine-induced internalization and receptor resensitization. J. Biol. Chem. 276, 31408-31414 (Pubitemid 37385013)
22. Pawar, M., Kumar, P., Sunkaraneni, S., Sirohi, S., Walker, E. A., and Yoburn, B. C. (2007) Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2. Eur. J. Pharmacol. 563, 92-101 (Pubitemid 46602222)
23. Koch, T., Widera, A., Bartzsch, K., Schulz, S., Brandenburg, L. O., Wundrack, N., Beyer, A., Grecksch, G., and Hollt, V. (2005) Receptor endocytosis counteracts the development of opioid tolerance. Mol. Pharmacol. 67, 280-287 (Pubitemid 40069989)
24. Whistler, J. L., Chuang, H. H., Chu, P., Jan, L. Y., and von Zastrow, M. (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23, 737-746 (Pubitemid 29411563)
25. Zollner, C., Mousa, S. A., Fischer, O., Rittner, H. L., Shaqura, M., Brack, A., Shakibaei, M., Binder, W., Urban, F., Stein, C., and Schafer, M. (2008) Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J. Clin. Invest. 118, 1065-1073
26. Finn, A. K., and Whistler, J. L. (2001) Endocytosis of the μ-opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 32, 829-839
27. Sharma, S. K., Klee, W. A., and Nirenberg, M. (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. U. S. A. 72, 3092-3096
28. Rasmussen, K., Beitner-Johnson, D. B., Krystal, J. H., Aghajanian, G. K., and Nestler, E. J. (1990) Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 10, 2308-2317
29. Avidor-Reiss, T., Nevo, I., Levy, R., Pfeuffer, T., and Vogel, Z. (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gβγ. J. Biol. Chem. 271, 21309-21315 (Pubitemid 26292991)
30. Williams, J. T., Christie, M. J., and Manzoni, O. (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81, 299-343
31. Nestler, E. J. (1996) Under siege: The brain on opiates. Neuron 16, 897-900
32. Bohn, L. M., Gainetdinov, R. R., Lin, F. T., Lefkowitz, R. J., and Caron, M. G. (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408, 720-723
33. Liu, J., Nickolenko, J., and Sharp, F. R. (1994) Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-d-aspartate receptors. Proc. Natl. Acad. Sci. U. S. A. 91, 8537-8541 (Pubitemid 24273699)
34. Trujillo, K. A. (2000) Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology 151, 121-141
35. Mao, J., Sung, B., Ji, R. R., and Lim, G. (2002) Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J. Neurosci. 22, 8312-8323 (Pubitemid 35379137)
36. Zeng, J., Thomson, L. M., Aicher, S. A., and Terman, G. W. (2006) Primary afferent NMDA receptors increase dorsal horn excitation and mediate opiate tolerance in neonatal rats. J. Neurosci. 26, 12033-12042 (Pubitemid 44772114)
37. Bajo, M., Crawford, E. F., Roberto, M., Madamba, S. G., and Siggins, G. R. (2006) Chronic morphine treatment alters expression of N-methyl-d-aspartate receptor subunits in the extended amygdala. J. Neurosci. Res. 83, 532-537 (Pubitemid 43384846)
38. Fitzgerald, L. W., Ortiz, J., Hamedani, A. G., and Nestler, E. J. (1996) Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 16, 274-282 (Pubitemid 26010716)
39. Resink, A., Villa, M., Benke, D., Hidaka, H., Mohler, H., and Balazs, R. (1996) Characterization of agonist-induced downregulation of NMDA receptors in cerebellar granule cell cultures. J. Neurochem. 66, 369-377 (Pubitemid 26010802)
40. Resink, A., Villa, M., Boer, G. J., Mohler, H., and Balazs, R. (1995) Agonist-induced down-regulation of NMDA receptors in cerebellar granule cells in culture. Eur. J. Neurosci. 7, 1700-1706
41. Thomson, F., and Craighead, M. (2008) Innovative approaches for the treatment of depression: targeting the HPA axis. Neurochem. Res. 33, 691-707 (Pubitemid 351341638)
42. Kolber, B. J., Wieczorek, L., and Muglia, L. J. (2008) Hypothalamic-pituitary-adrenal axis dysregulation and behavioral analysis of mouse mutants with altered glucocorticoid or mineralocorticoid receptor function. Stress 11, 321-338
43. De Kloet, E. R., de Jong, I. E., and Oitzl, M. S. (2008) Neuropharmacology of glucocorticoids: focus on emotion, cognition and cocaine. Eur. J. Pharmacol. 585, 473-482
44. Koob, G. F. (2008) A role for brain stress systems in addiction. Neuron 59, 11-34
45. Lim, G., Wang, S., Zeng, Q., Sung, B., and Mao, J. (2005) Evidence for a long-term influence on morphine tolerance after previous morphine exposure: role of neuronal glucocorticoid receptors. Pain 114, 81-92 (Pubitemid 40279090)
46. David, V., Matifas, A., Gavello-Baudy, S., Decorte, L., Kieffer, B. L., and Cazala, P. (2008) Brain regional Fos expression elicited by the activation of μ- but not -opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward. Neuropsychopharmacology 33, 1746-1759 (Pubitemid 351684698)
47. Erdtmann-Vourliotis, M., Mayer, P., Linke, R., Riechert, U., and Hollt, V. (1999) Long-lasting sensitization towards morphine in motoric and limbic areas as determined by c-fos expression in rat brain. Brain Res. Mol. Brain Res. 72, 1-16 (Pubitemid 29474910)
48. Erdtmann-Vourliotis, M., Mayer, P., Riechert, U., Grecksch, G., and Hollt, V. (1998) Identification of brain regions that are markedly activated by morphine in tolerant but not in naive rats. Brain Res. Mol. Brain Res. 61, 51-61 (Pubitemid 28511347)
49. Nye, H. E., and Nestler, E. J. (1996) Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49, 636-645 (Pubitemid 26117147)
50. Ferguson, S. M., Thomas, M. J., and Robinson, T. E. (2004) Morphine-induced c-fos mRNA expression in striatofugal circuits: modulation by dose, environmental context, and drug history. Neuropsychopharmacology 29, 1664-1674